Company / PP&E per Share
Haemonetics PP&E per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$5.59
FY2025
5-year range
$4.24 / $6.17
FY2021-FY2025
Trend
-9.4%
vs FY2024
Sector context
#48 of 133
Health Care
What the data says
At $5.59, Haemonetics's pp&e per share ranks #48 of 133 in the Health Care sector. PP&E per Share has fluctuated over the past 10 years, ranging from $4.24 in FY2021 to $6.64 in FY2019.
Based on SEC 10-K filings.
5.59 in FY2025 with a 5-year CAGR of +2.5%.
Declined from $6.05 to $5.59 over the past 2 years.
Health Care sector context is included.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- +3.6%
- 5-Year CAGR
- +2.5%
- 10-Year CAGR
- -
Sector benchmark
#48 of 133 in Health CareTop 36% of 133This company $5.59 Sector average $11.64
▼
-51.9% below sector average
Key checks
Key Insights
- In FY2025, pp&e per share decreased 9.4% year-over-year.
- Ranks #48 out of 133 companies in the Health Care sector.
- Peak pp&e per share was recorded in FY2019.
- Lowest pp&e per share in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score 0.44 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.59 | -9.4% |
| FY2024 | $6.17 | +2.0% |
| FY2023 | $6.05 | +20.3% |
| FY2022 | $5.03 | +18.7% |
| FY2021 | $4.24 | -14.2% |
| FY2020 | $4.94 | -25.6% |
| FY2019 | $6.64 | +4.4% |
| FY2018 | $6.36 | -0.0% |
| FY2017 | $6.36 | -2.7% |
| FY2016 | $6.53 | +5.6% |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026